PLA2G4A - phospholipase A2 group IVA Gene

Also Known as GURDP; cPLA2; PLA2G4; cPLA2-alpha

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 5321

About PLA2G4A

Cytogenetic location: 1q31.1 Genomic coordinates (GRCh38): 1:186,828,949-186,988,981 (from NCBI)

This gene has 2 transcripts (splice variants), 237 orthologues, 5 paralogues and is associated with 3 phenotypes. Ubiquitous expression in urinary bladder (RPKM 6.0), adrenal (RPKM 5.6) and 24 other tissues.

Summary

This gene encodes a member of the cytosolic Phospholipase A2 group IV family. The enzyme catalyzes the hydrolysis of membrane Phospholipids to release arachidonic acid which is subsequently metabolized into eicosanoids. Eicosanoids, including prostaglandins and leukotrienes, are lipid-based cellular Hormones that regulate hemodynamics, inflammatory responses, and Other intracellular pathways. The hydrolysis reaction also produces lysophospholipids that are converted into platelet-activating factor. The enzyme is activated by increased intracellular CA(2+) levels and phosphorylation, resulting in its translocation from the cytosol and nucleus to perinuclear membrane vesicles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]

PLA2G4A Products (2)

mRNA Protein Name
NM_001311193.2 NP_001298122.2 cytosolic phospholipase A2 isoform 2
NM_024420.3 NP_077734.2 cytosolic phospholipase A2 isoform 1
Molecular Function GO Annotation Evidence References Source
enables O-acyltransferase activity IDA
IDA: Inferred from direct assay
7794891 GOA
enables calcium ion binding IDA
IDA: Inferred from direct assay
9430701 GOA
enables calcium-dependent phospholipase A2 activity IDA
IDA: Inferred from direct assay
7794891 GOA
enables calcium-dependent phospholipase A2 activity IMP
IMP: Inferred from mutant phenotype
18451993 GOA
enables calcium-dependent phospholipid binding IDA
IDA: Inferred from direct assay
9665851 GOA
enables calcium-independent phospholipase A2 activity IDA
IDA: Inferred from direct assay
12672805 GOA
enables ceramide 1-phosphate binding IDA
IDA: Inferred from direct assay
17472963 GOA
enables lysophospholipase activity IDA
IDA: Inferred from direct assay
12672805 GOA
enables phosphatidylinositol-3-phosphate binding IDA
IDA: Inferred from direct assay
12672805 GOA
enables phosphatidylinositol-4-phosphate binding IDA
IDA: Inferred from direct assay
12672805 GOA
enables phosphatidylinositol-5-phosphate binding IDA
IDA: Inferred from direct assay
12672805 GOA
enables phospholipase A2 activity IDA
IDA: Inferred from direct assay
8702602 GOA
Biological Process GO Annotation Evidence References Source
involved in arachidonate metabolic process IDA
IDA: Inferred from direct assay
7794891 GOA
involved in leukotriene biosynthetic process IMP
IMP: Inferred from mutant phenotype
18451993 GOA
involved in monoacylglycerol biosynthetic process IDA
IDA: Inferred from direct assay
7794891 GOA
involved in phosphatidylcholine acyl-chain remodeling IDA
IDA: Inferred from direct assay
16617059 GOA
involved in phosphatidylcholine catabolic process IDA
IDA: Inferred from direct assay
7794891 GOA
involved in phosphatidylglycerol catabolic process IDA
IDA: Inferred from direct assay
9425121 GOA
involved in positive regulation of platelet activation IMP
IMP: Inferred from mutant phenotype
18451993 GOA
involved in prostaglandin biosynthetic process IDA
IDA: Inferred from direct assay
27642067 GOA
involved in prostaglandin biosynthetic process IMP
IMP: Inferred from mutant phenotype
18451993 GOA
Cellular Component GO Annotation Evidence References Source
located in Golgi membrane IDA
IDA: Inferred from direct assay
11375391 GOA
located in cytoplasm IDA
IDA: Inferred from direct assay
11375391 GOA
located in nuclear envelope IDA
IDA: Inferred from direct assay
11375391 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

PLA2G4A Protein Structure

C2

C2: C2 domain (22 - 106)

PLA2_B

PLA2_B: Lysophospholipase catalytic domain (190 - 674)

  • 0
  • 200
  • 400
  • 600
  • 749 a.a.
Protein Preferred Names Protein Names

cytosolic phospholipase A2

  • calcium-dependent phospholipid-binding protein

PLA2G4A Antibodies

Cat. No. Product Name Application Reactivity
HY-P87025 Phospho-Cytosolic Phospholipase A2 (S505) Antibody (YA6718) WB, Dot Blot Human, Mouse

Related Diseases

Diseases Alias
Gastrointestinal Ulceration, Recurrent, With Dysfunctional Platelets
  • Cytosolic Phospholipase-A2 Alpha Deficiency Associated Bleeding Disorder

  • GURDP

  • Deficiency Of Phospholipase A2, Group Iva

  • Phospholipase A2, Group Iva, Deficiency Of

  • Pla2g4a-Related Platelet Dysfunction

  • Platelet Dysfunction Due To Cytosolic Phospholipase-A2 Alpha Deficiency

Cryptogenic Multifocal Ulcerous Stenosing Enteritis
  • Cmuse

  • Cmuse - [Cryptogenic Multifocal Ulcerous Stenosing Enteritis]

Hypereosinophilic Syndrome
  • Eosinophilia

  • HES

  • Eosinophilic Leukocytosis

  • Hypereosinophilic Syndrome, Idiopathic

  • Idiopathic Hypereosinophilic Syndrome

  • Disseminated Eosinophilic Collagen Disease

  • Eosinophilic Disorder

  • Disorders With Increased Eosinophil Counts

Arthritis
  • Inflammatory Joint Disease

  • Inflammatory Disorder Of Joint

Familial Adenomatous Polyposis
  • Adenomatous Polyposis Coli

  • Fap

  • Familial Polyposis Coli

  • Familial Multiple Polyposis Syndrome

  • Adenomatous Polyposis Of The Colon

  • Familial Intestinal Polyposis

  • Fpc

  • Familial Adenomatous Polyposis Of The Colon

  • Familial Multiple Polyposis

  • Familial Polyposis Of The Colon

  • Hereditary Polyposis Coli

  • Polyposis, Adenomatous Intestinal

  • Adenomatous Familial Polyposis

  • Adenomatous Familial Polyposis Syndrome

  • Myh-Associated Polyposis

  • Colorectal Adenomatous Polyposis

  • Adenomatous Polyposis, Familial

  • Mutyh-Associate Polyposis

Primary Hypertrophic Osteoarthropathy
  • Pachydermoperiostosis Syndrome

  • Osteoarthropathy, Primary Hypertrophic

  • Pachydermoperiostosis Of Nail

  • Idiopathic Hypertrophic Osteoarthropathy

  • Pho

Asthma
  • Chronic Obstructive Asthma

  • Asthma, Diminished Response To Antileukotriene Treatment In

  • Bronchial Hyperreactivity

  • Asthma, Susceptibility To

  • Asthma, Bronchial

  • Asthma, Protection Against

  • Asthma, Nocturnal, Susceptibility To

  • Nocturnal Asthma

  • Asthma-Related Traits

  • Asthma-Related Traits, Susceptibility To

  • Asthma, Nocturnal

  • Chronic Obstructive Asthma With Acute Exacerbation

  • Chronic Obstructive Asthma With Status Asthmaticus

  • Exercise Induced Asthma

  • Exercise-Induced Asthma

  • Bronchial Asthma

  • Asthma, Exercise-Induced

  • Idiosyncratic Asthma

  • Unspecified Asthma With Acute Exacerbation

  • Asthma, Unspecified, With Stated Status Asthmaticus

  • Status Asthmaticus Nos

  • Acute Severe Asthma

  • Acute Severe Bronchial Asthma

  • Status Asthma

  • Status Post Asthmaticus

Colorectal Cancer
  • Colon Cancer

  • Colorectal Carcinoma

  • Colon Carcinoma

  • Colorectal Cancer, Susceptibility To

  • Carcinoma Of Colon

  • CRC

  • Colorectal Cancer With Chromosomal Instability, Somatic

  • Colon Cancer, Somatic

  • Colon Cancer, Susceptibility To

  • Colonic Neoplasms

  • Colorectal Neoplasms

  • Colorectal Cancer, Somatic

  • Colon Cancer, Advanced, Somatic

  • Colonic Carcinoma

  • Colorectal Carcinomas

  • Colon Cancers

  • Colorectal Cancers

  • Cancer, Colorectal, Somatic

  • Cancer, Colon

  • Cancer, Colorectal, Susceptibility To

  • Colorectal Neoplasm

  • Colonic Neoplasm

  • Malignant Tumor Of Colon

Cholangiocarcinoma
  • Cholangiocarcinoma, Susceptibility To

  • Extrahepatic Cholangiocarcinoma

  • Intrahepatic Cholangiocarcinoma

  • Chlc

  • Chlc, Susceptibility To

  • Cc

  • Cholangiocarcinoma Of Biliary Tract

  • Cholangiocellular Carcinoma

  • Distal Cholangiocarcinoma

  • Perihilar Cholangiocarcinoma

  • Bile Duct Cancer

  • Cca

  • Adult Primary Cholangiocellular Carcinoma

  • Bile Duct Carcinoma

Cystic Fibrosis
  • Mucoviscidosis

  • CF

  • Pseudomonas Aeruginosa, Susceptibility To Chronic Infection By, In Cystic Fibrosis

  • Pseudomonas Aeruginosa Chronic Infection By, In Cystic Fibrosis

  • Cystic Fibrosis Lung Disease, Modifier Of

  • Cystic Fibrosis Of Pancreas

  • Fibrocystic Disease Of Pancreas

  • Cf - [Cystic Fibrosis]

  • Cystic Fibrosis Nos

  • Fibrocystic Disease

  • Fibrocystic Disease Of The Pancreas

  • Mucoviscidosis Of Pancreas

  • Nonproliferative Fibrocystic Disease

  • Pancreatic Cystic Fibrosis

Schizophrenia
  • SCZD

  • Schizophrenia With Or Without An Affective Disorder

  • Schizophrenia 12

  • Schizophrenia, Susceptibility To

  • Schizophrenia-1

  • Dementia Praecox

  • Schizophrenia 1

Alzheimer Disease, Familial, 1
  • Alzheimer Disease

  • Alzheimer'S Disease

  • Presenile And Senile Dementia

  • AD1

  • Alzheimer Disease, Susceptibility To

  • Alzheimer Disease, Late-Onset, Susceptibility To

  • Alzheimer Disease 1, Familial

  • AD

  • Familial Alzheimer Disease

  • Alzheimer Disease, Late-Onset

  • Alzheimers Dementia

  • Alzheimer Dementia

  • Alzheimer Sclerosis

  • Alzheimer Syndrome

  • Alzheimer-Type Dementia

  • Dat

  • Primary Senile Degenerative Dementia

  • Sdat

  • Alzheimer Disease 1

  • Autosomal Dominant Alzheimer Disease

  • Early-Onset Alzheimer Disease With Cerebral Amyloid Angiopathy

  • Late Onset Alzheimer Disease

  • Alzheimers Disease

  • Alzheimer Disease, Early-Onset, With Cerebral Amyloid Angiopathy

  • Late-Onset Alzheimers Disease

  • Alzheimer'S Disease Pathway Kegg

  • Dementia Due To Alzheimer'S Disease

  • Alzheimer Disease Type 1

  • Alzheimers

Body Mass Index Quantitative Trait Locus 11
  • OBESITY

  • Obesity, Susceptibility To

  • Leanness, Inherited

  • Obesity, Susceptibility To, Bmiq11

  • Obesity, Mild, Early-Onset

  • Obesity, Association With

  • Obesity, Early-Onset, Susceptibility To

  • Obesity, Severe

  • Obesity, Severe, And Type Ii Diabetes

  • Obesity, Late-Onset

  • Obesity , Susceptibility To

  • BMIQ11

  • Obesity Bmiq11

  • Obesity, Early-Onset

  • Simple Obesity Nos

  • Excess Fat

  • Obesity, Not Elsewhere Classified, Body Mass Index Not Elsewhere Classified

  • Adiposis

Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Orthologs Information

Species Symbol Source ID
Canis familiaris PLA2G4A VGNC VGNC:44626
Rattus norvegicus PLA2G4A RGD RGD:67366
Mus musculus PLA2G4A MGD MGI:1195256
Felis catus PLA2G4A VGNC VGNC:68881
Macaca mulatta PLA2G4A VGNC VGNC:76156
Bos taurus PLA2G4A VGNC VGNC:32960
Others PLA2G4A NCBI